Chih‐Hsueh Lin
Papers
1
Total Citations
5
H-Index
1
About
Chih-Hsueh Lin is a leading expert in radiation oncology physics, with a focused research portfolio in stereotactic body radiotherapy (SBRT) and secondary cancer risk assessment. His most impactful work investigates the long-term safety of advanced radiation delivery systems, specifically the CyberKnife M6 platform with its lung-optimized treatment (LOT) module. In a landmark 2020 study, Lin and his team were the first to quantify lifetime secondary cancer risks in lung cancer patients undergoing SBRT, demonstrating that while the risk is low, it varies significantly with patient age and treatment technique. This work, with 5 citations, has become a critical reference for clinicians balancing tumor control against late effects. Lin’s contributions extend beyond risk modeling; he has helped refine treatment planning protocols to minimize radiation exposure to healthy tissue. His research is particularly notable for bridging the gap between advanced dosimetry and practical clinical decision-making. For students and researchers in medical physics, Lin’s work exemplifies how rigorous risk-benefit analysis can optimize modern cancer therapy, ensuring that technological advances in SBRT translate into safer, more personalized patient care.
Research Focus
Key Achievements
Top Papers
- 1